Titre : Régulon

Régulon : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cognitive Dysfunction
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Régulon : Questions médicales les plus fréquentes", "headline": "Régulon : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Régulon : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-26", "dateModified": "2025-03-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Régulon" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composants de génome", "url": "https://questionsmedicales.fr/mesh/D040481", "about": { "@type": "MedicalCondition", "name": "Composants de génome", "code": { "@type": "MedicalCode", "code": "D040481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.024" } } }, "about": { "@type": "MedicalCondition", "name": "Régulon", "alternateName": "Regulon", "code": { "@type": "MedicalCode", "code": "D018085", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bernhard O Palsson", "url": "https://questionsmedicales.fr/author/Bernhard%20O%20Palsson", "affiliation": { "@type": "Organization", "name": "Department of Bioengineering, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Ye Gao", "url": "https://questionsmedicales.fr/author/Ye%20Gao", "affiliation": { "@type": "Organization", "name": "Department of Biological Sciences, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Yara Seif", "url": "https://questionsmedicales.fr/author/Yara%20Seif", "affiliation": { "@type": "Organization", "name": "Department of Bioengineering, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Doron Teper", "url": "https://questionsmedicales.fr/author/Doron%20Teper", "affiliation": { "@type": "Organization", "name": "Citrus Research and Education Center, Department of Microbiology and Cell Sciences, University of Florida, 700 Experiment Station Road, Lake Alfred FL 33850, U.S.A." } }, { "@type": "Person", "name": "Nian Wang", "url": "https://questionsmedicales.fr/author/Nian%20Wang", "affiliation": { "@type": "Organization", "name": "Citrus Research and Education Center, Department of Microbiology and Cell Sciences, University of Florida, 700 Experiment Station Road, Lake Alfred FL 33850, U.S.A." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36251860", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13506129.2022.2131384" } }, { "@type": "ScholarlyArticle", "name": "Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.", "datePublished": "2024-09-13", "url": "https://questionsmedicales.fr/article/39346594", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2024.1385089" } }, { "@type": "ScholarlyArticle", "name": "Reward network dysfunction is associated with cognitive impairment after stroke.", "datePublished": "2023-05-31", "url": "https://questionsmedicales.fr/article/37307650", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.nicl.2023.103446" } }, { "@type": "ScholarlyArticle", "name": "Predictors of cognitive dysfunction one-year post COVID-19.", "datePublished": "2023-01-05", "url": "https://questionsmedicales.fr/article/36603126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1037/neu0000876" } }, { "@type": "ScholarlyArticle", "name": "Cognitive Dysfunction Biomarkers in Patients With Rheumatoid Arthritis: A Systematic Review.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36729842", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/RHU.0000000000001888" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Génome", "item": "https://questionsmedicales.fr/mesh/D016678" }, { "@type": "ListItem", "position": 5, "name": "Composants de génome", "item": "https://questionsmedicales.fr/mesh/D040481" }, { "@type": "ListItem", "position": 6, "name": "Régulon", "item": "https://questionsmedicales.fr/mesh/D018085" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Régulon - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Régulon", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Régulon", "description": "Comment savoir si le Régulon est adapté ?\nQuels tests sont nécessaires avant de commencer le Régulon ?\nLe Régulon nécessite-t-il un suivi médical ?\nQuels signes indiquent une mauvaise tolérance au Régulon ?\nLe Régulon est-il efficace dès le premier jour ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Cognitive+Dysfunction&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Régulon", "description": "Quels sont les effets secondaires courants du Régulon ?\nLe Régulon peut-il provoquer des douleurs abdominales ?\nComment reconnaître une réaction allergique au Régulon ?\nLe Régulon peut-il affecter l'humeur ?\nQuels symptômes nécessitent d'arrêter le Régulon ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Cognitive+Dysfunction&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Régulon", "description": "Comment le Régulon prévient-il la grossesse ?\nLe Régulon est-il efficace pour réguler le cycle menstruel ?\nQuels conseils pour maximiser l'efficacité du Régulon ?\nLe Régulon peut-il être utilisé comme traitement hormonal ?\nEst-il nécessaire de consulter un médecin avant de commencer le Régulon ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Cognitive+Dysfunction&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Régulon", "description": "Comment prendre le Régulon correctement ?\nQue faire en cas d'oubli d'une pilule ?\nLe Régulon peut-il être pris avec d'autres médicaments ?\nCombien de temps peut-on prendre le Régulon ?\nLe Régulon protège-t-il contre les IST ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Cognitive+Dysfunction&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Régulon", "description": "Quelles sont les complications possibles du Régulon ?\nComment reconnaître un caillot sanguin lié au Régulon ?\nLe Régulon augmente-t-il le risque de cancer ?\nQuels signes d'AVC doivent alerter ?\nLe Régulon peut-il causer des problèmes de foie ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Cognitive+Dysfunction&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Régulon", "description": "Qui devrait éviter le Régulon ?\nLe tabagisme influence-t-il l'utilisation du Régulon ?\nLes femmes obèses doivent-elles être prudentes avec le Régulon ?\nLes antécédents familiaux de cancer influencent-ils le choix ?\nLe Régulon est-il sûr pour les femmes âgées ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Cognitive+Dysfunction&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment savoir si le Régulon est adapté ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un médecin évalue l'historique médical et les besoins contraceptifs." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant de commencer le Régulon ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique et éventuellement des tests sanguins pour vérifier la santé." } }, { "@type": "Question", "name": "Le Régulon nécessite-t-il un suivi médical ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi est recommandé pour évaluer l'efficacité et les effets secondaires." } }, { "@type": "Question", "name": "Quels signes indiquent une mauvaise tolérance au Régulon ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des saignements irréguliers ou des nausées persistantes." } }, { "@type": "Question", "name": "Le Régulon est-il efficace dès le premier jour ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il est efficace immédiatement si pris au début du cycle menstruel." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants du Régulon ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Nausées, maux de tête, changements d'humeur et saignements irréguliers." } }, { "@type": "Question", "name": "Le Régulon peut-il provoquer des douleurs abdominales ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines femmes peuvent ressentir des douleurs abdominales légères." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique au Régulon ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des démangeaisons, éruptions cutanées ou gonflements peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Le Régulon peut-il affecter l'humeur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements d'humeur peuvent survenir en raison des hormones." } }, { "@type": "Question", "name": "Quels symptômes nécessitent d'arrêter le Régulon ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, des maux de tête sévères ou des troubles de la vision." } }, { "@type": "Question", "name": "Comment le Régulon prévient-il la grossesse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il empêche l'ovulation et rend la muqueuse utérine moins réceptive aux spermatozoïdes." } }, { "@type": "Question", "name": "Le Régulon est-il efficace pour réguler le cycle menstruel ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut aider à réguler les cycles menstruels irréguliers chez certaines femmes." } }, { "@type": "Question", "name": "Quels conseils pour maximiser l'efficacité du Régulon ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Prenez-le à la même heure chaque jour et évitez les interactions médicamenteuses." } }, { "@type": "Question", "name": "Le Régulon peut-il être utilisé comme traitement hormonal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être prescrit pour traiter des troubles hormonaux comme l'endométriose." } }, { "@type": "Question", "name": "Est-il nécessaire de consulter un médecin avant de commencer le Régulon ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consultation médicale est essentielle pour évaluer les risques et bénéfices." } }, { "@type": "Question", "name": "Comment prendre le Régulon correctement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Prenez un comprimé chaque jour à la même heure pour une efficacité optimale." } }, { "@type": "Question", "name": "Que faire en cas d'oubli d'une pilule ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Prenez la pilule oubliée dès que possible, mais ne doublez pas la dose." } }, { "@type": "Question", "name": "Le Régulon peut-il être pris avec d'autres médicaments ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent interférer avec le Régulon, consultez un médecin." } }, { "@type": "Question", "name": "Combien de temps peut-on prendre le Régulon ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il peut être pris pendant plusieurs années, mais un suivi médical est nécessaire." } }, { "@type": "Question", "name": "Le Régulon protège-t-il contre les IST ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, le Régulon ne protège pas contre les infections sexuellement transmissibles." } }, { "@type": "Question", "name": "Quelles sont les complications possibles du Régulon ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des caillots sanguins, AVC ou hypertension." } }, { "@type": "Question", "name": "Comment reconnaître un caillot sanguin lié au Régulon ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs soudaines dans la jambe, gonflement ou rougeur peuvent indiquer un caillot." } }, { "@type": "Question", "name": "Le Régulon augmente-t-il le risque de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent un risque légèrement accru de cancer du sein, mais les données sont variées." } }, { "@type": "Question", "name": "Quels signes d'AVC doivent alerter ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des maux de tête soudains, troubles de la parole ou paralysie d'un côté du corps." } }, { "@type": "Question", "name": "Le Régulon peut-il causer des problèmes de foie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles hépatiques peuvent survenir, surtout chez les femmes avec antécédents." } }, { "@type": "Question", "name": "Qui devrait éviter le Régulon ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes avec des antécédents de caillots sanguins ou AVC devraient l'éviter." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il l'utilisation du Régulon ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de complications cardiovasculaires avec le Régulon." } }, { "@type": "Question", "name": "Les femmes obèses doivent-elles être prudentes avec le Régulon ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité peut augmenter le risque de complications liées au Régulon." } }, { "@type": "Question", "name": "Les antécédents familiaux de cancer influencent-ils le choix ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer peuvent nécessiter une évaluation plus approfondie." } }, { "@type": "Question", "name": "Le Régulon est-il sûr pour les femmes âgées ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes de plus de 35 ans, surtout fumeuses, doivent consulter un médecin avant de l'utiliser." } } ] } ] }

Sources (10000 au total)

Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.

Cognitive dysfunction is part of the broad spectrum of clinical manifestations in older untreated hereditary transthyretin amyloidosis patients with peripheral polyneuropathy.... The objective of this study is to systematically explore cognitive dysfunction in ATTRV30M amyloidosis patients whose disease course was modified by liver transplant (LT).... A series of 269 carriers of TTRVal30Met mutation treated with LT underwent a neuropsychological assessment. Clinical charts were reviewed to identify focal neurological episodes (FNEs), cognitive comp... Cognitive dysfunction was identified in 35 patients (13%)-14 (5%) had mild and 21 (8%) had moderate dysfunction. In comparison to normal cognition, both mild and moderate cognitive dysfunction patient... Consistent with the natural history of the disease, older age and higher severity of the disease are significantly associated and potentially predictors of cognitive dysfunction in ATTRV30M patients t...

Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.

The impact of cardiovascular diseases on cognition raises important research questions. The study aimed to investigate the relationship between demographic data, cardiovascular diseases, kidney diseas... A cross-sectional study of patients with cardiovascular diseases was performed. The Montreal Cognitive Assessment (MoCA) was applied for cognitive evaluation. Based on MoCA three groups were defined: ... Of 628 patients, 55.2% had mild CD, and the mean age was 67.95 (SD 9.53) years. Cα and Mω were 0.7, indicating good internal consistency. We found a moderate positive correlation between depression an... Mild CD was the most common in patients with cardiovascular diseases. Older age, lower education, being a non-smoker, and renal dysfunction were risk factors for both mild and advanced CD. Female gend...

Predictors of cognitive dysfunction one-year post COVID-19.

(a) To characterize the frequency of objective cognitive deficits and self-perceived cognitive difficulties and (b) to explore demographic and clinical predictors of cognitive dysfunction and cognitiv... One hundred and ten adults diagnosed with COVID-19 between March and November 2020, aged ≤ 74 years underwent a brief neuropsychological evaluation 12 months after infection, which included: Brief Vis... Twenty participants (18.2%) had cognitive dysfunction and 36 (33.3%) had cognitive complaints. Cognitive dysfunction was related to lower education, preinfection history of headache/migraine, and acut... A subset of individuals develops cognitive difficulties in the context of post-COVID syndrome. Results may support the protective effect of education, a known proxy of cognitive reserve. COVID-19 infe...

Cognitive Dysfunction Biomarkers in Patients With Rheumatoid Arthritis: A Systematic Review.

During the last years, a growing number of studies have investigated the link between cognitive dysfunction and rheumatoid arthritis (RA), highlighting the potential pathogenic role of several clinica... We performed a systematic review using PRISMA (Preferred Reported Items for Systematic Reviews and Meta-analysis) protocol. A systematic search was conducted in the PubMed/MEDLINE, EMBASE, LILACS, Sco... Five original studies were included, which provided data from 428 participants. Among plasma proteins, SHH was increased and TTR was reduced in patients with mild cognitive impairment; anti-myelin bas... Despite the relative scarcity of studies on this subject and the heterogeneity of results, we identified possible biomarkers for cognitive deficits in the RA population. Further longitudinal studies a...

Endothelial Dysfunction and Pre-Existing Cognitive Disorders in Stroke Patients.

The origin of pre-existing cognitive impairment in stroke patients remains controversial, with a vascular or a degenerative hypothesis.... To determine whether endothelial dysfunction is associated with pre-existing cognitive problems, lesion load and biological anomalies in stroke patients.... Patients originated from the prospective STROKDEM study. The baseline cognitive state, assessed using the IQ-CODE, and risk factors for stroke were recorded at inclusion. Patients with an IQ-CODE scor... A total of 86 patients were included (52 males; mean age 63.5 ± 11.5 years). Patients with abnormal RHI have hypertension or antihypertensive treatment more often. The baseline IQ-CODE was abnormal in... A vascular mechanism may be responsible for cognitive problems pre-existing stroke. The measurement of endothelial dysfunction after stroke could become an important element of follow-up, providing an...

Cognitive Dysfunction in Heart Failure: Pathophysiology and Implications for Patient Management.

There is increasing recognition of the prevalence and impact of cognitive dysfunction (CD) in heart failure (HF) patients. This contemporary review appraises the evidence for epidemiological associati... CD disproportionately affects heart failure patients, even accounting for known comorbid risk factors, and this may extend to subclinical left ventricular dysfunction. Neuroimaging studies now provide...

Frequency and risk factors for cognitive dysfunction in peritoneal dialysis patients.

There is limited data on cognition in patients undergoing peritoneal dialysis (PD). We assessed prevalence and associated risk factors of neurocognitive impairment (NCI) in PD patients.... A cross-sectional cohort study of 149 PD patients at a single centre between 2016 and 2020 who underwent neurocognitive screening at defined intervals by Addenbrooke's Cognitive Examination - Revised ... Patients on PD performed poorly in ACE-R screening compared to population norms, with discrepancy in all cognitive domains. In patients without CVD, attention and language domains were comparable to n... Patients on PD have higher prevalence of NCI than the general population, primarily with impairments in memory, fluency and visuospatial reasoning. CVD confers poorer performance in attention and lang...